(Q38318241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Yan Lu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Zhimin Ma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Zhijian Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Xuelian Xiong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Xiaolin Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Huijie Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Xuefeng Xia

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Guang Ning

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Xiaoying Li

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

24 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

170-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic fatty liver disease

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Human fatty liver disease: old questions and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Epidemiology of nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Gene expression in human NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Transcription factor YY1 promotes adipogenesis via inhibiting CHOP-10 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Mouse obesity network reconstruction with a variational Bayes algorithm to employ aggressive false positive control

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

SREBPs: sterol-regulated transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Toll-like receptors: linking inflammation to metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Yin Yang 1, Oct1, and NFAT-4 form repeating, cyclosporin-sensitive regulatory modules within the murine CD21 intronic control region

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

YY1 binding within the human HSD3B2 gene intron 1 is required for maximal basal promoter activity: identification of YY1 as the 3beta1-A factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

YY1 repressing peroxisome proliferator-activated receptor delta promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Yin Yang 1 regulates the transcriptional activity of androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Identification of a nuclear receptor for bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Glucose regulates the expression of the farnesoid X receptor in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Targeting farnesoid X receptor for liver and metabolic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Nuclear receptors reverse McGarry's vicious cycle to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303150

10.1136/GUTJNL-2012-303150

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference